EN  |  JP

CMIC Resources

CMIC Resources

Solution Area

View All







Resource Type

View All










CDMO | Clinical | Consulting | CSO | Healthcare | Japan Market Entry | Non-Clinical / Brochures

The first and largest CRO in Japan offers you services […]

CDMO | Clinical | Consulting | CSO | Healthcare | Japan Market Entry | Non-Clinical / Brochures

CMIC Group Overview, as of December 2023. Corporate Overview History […]

CDMO / Brochures

Your Strategic Partner for Expert Drug Development and Manufacturing Fully […]

CDMO | Clinical | Consulting | CSO | Healthcare | Japan Market Entry | Non-Clinical / Brochures

We sincerely appreciate your support during our 30 year journey!​ […]

CDMO | Clinical | Consulting | CSO | Healthcare | Japan Market Entry | Non-Clinical / Featured Articles

This is the article originally published in Newsweek on November […]

CDMO / C-CAST

C-CAST is a mini-video series presented by CMIC Group. As […]

CDMO / Blog

Since its introduction in the 1980s, the market of orally […]

CDMO | Clinical / Webinars

The COVID-19 global pandemic took the world by storm, disrupting […]

CDMO / White Papers

Virtual pharmaceutical companies often have strong regulatory and clinical teams, […]

CDMO / C-CAST / Video

Executive interview with CMIC CDMO CEO, Makoto Matsukawa Interview Includes: […]

CDMO / Video

Learn more about CMIC Group’s parenteral drug manufacturing building of […]

CDMO / Video

Your Strategic Partner for Expert Drug Development and Manufacturing  As […]

CDMO / White Papers

Development and Manufacturing: Insights into the Precision Medicine Model  Download […]

CDMO | Clinical | Consulting | CSO | Healthcare | Japan Market Entry | Non-Clinical / Video

CMIC was founded in 1992 as the first contract research […]

CDMO / eBook

April 2020, Pharmaceutical Technology Download this eBook to learn more […]

CDMO / Brochures

Your Strategic Partner for Expert Drug Development and Manufacturing Bridging […]

CDMO / eBook

Contract manufacturers are right at the center of the transformation that is reshaping the pharmaceutical and biotech industry. Their central position brings opportunities and challenges that keep them striving to stay on top of quality, technological innovation and safety and regulatory considerations. The flip side of this is working strategically to ensure the right business decisions are made, managing costs and astutely investing in technology.

CDMO / Webinars

Since its introduction in the 1980s, the market of orally disintegrating tablet (ODT) has grown annually and ODTs are now available in a variety of therapeutic areas, both over-the-counter (OTC) and by prescription. ODT market is projected to reach US$21B in 2023. In this webinar, CMIC and Aprecia experts talked about advanced ODT technologies and its advantages in drug development.

Inquiries-RGB

Inquiries about our services

Click below if you are interested in outsourcing your operations to us.

Contact Us